[Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].
Identifieur interne : 000073 ( PubMed/Corpus ); précédent : 000072; suivant : 000074[Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].
Auteurs : M. Besbes ; W. Siala ; J. DaoudSource :
- Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique [ 1278-3218 ] ; 2003.
English descriptors
- KwdEn :
- MESH :
- etiology : Thyroid Diseases.
- radiation effects : Thyroid Gland.
- radiotherapy : Breast Neoplasms, Carcinoma, Nasopharyngeal Neoplasms.
- Adult, Female, Humans, Male, Radiation Injuries, Radiometry.
Abstract
The thyroid dysfunction after radiotherapy has led to evaluate the dose received by thyroid during nasopharynx and breast carcinoma irradiation. This evaluation was facilitated by in vivo dosimetry. The aims of this work were to evaluate the thyroid dose and to compare released dose at the reference point in the two localizations.
PubMed: 14522349
Links to Exploration step
pubmed:14522349Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">[Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].</title><author><name sortKey="Besbes, M" sort="Besbes, M" uniqKey="Besbes M" first="M" last="Besbes">M. Besbes</name><affiliation><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaiz, boulevard du 9-avril-Bab-Saadoun, 1006 Tunis, Tunisie.</nlm:affiliation></affiliation></author><author><name sortKey="Siala, W" sort="Siala, W" uniqKey="Siala W" first="W" last="Siala">W. Siala</name></author><author><name sortKey="Daoud, J" sort="Daoud, J" uniqKey="Daoud J" first="J" last="Daoud">J. Daoud</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2003">2003</date><idno type="RBID">pubmed:14522349</idno><idno type="pmid">14522349</idno><idno type="wicri:Area/PubMed/Corpus">000073</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000073</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">[Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].</title><author><name sortKey="Besbes, M" sort="Besbes, M" uniqKey="Besbes M" first="M" last="Besbes">M. Besbes</name><affiliation><nlm:affiliation>Service de radiothérapie carcinologique, institut Salah-Azaiz, boulevard du 9-avril-Bab-Saadoun, 1006 Tunis, Tunisie.</nlm:affiliation></affiliation></author><author><name sortKey="Siala, W" sort="Siala, W" uniqKey="Siala W" first="W" last="Siala">W. Siala</name></author><author><name sortKey="Daoud, J" sort="Daoud, J" uniqKey="Daoud J" first="J" last="Daoud">J. Daoud</name></author></analytic><series><title level="j">Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</title><idno type="ISSN">1278-3218</idno><imprint><date when="2003" type="published">2003</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term><term>Breast Neoplasms (radiotherapy)</term><term>Carcinoma (radiotherapy)</term><term>Female</term><term>Humans</term><term>Male</term><term>Nasopharyngeal Neoplasms (radiotherapy)</term><term>Radiation Injuries</term><term>Radiometry</term><term>Thyroid Diseases (etiology)</term><term>Thyroid Gland (radiation effects)</term></keywords><keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Thyroid Diseases</term></keywords><keywords scheme="MESH" qualifier="radiation effects" xml:lang="en"><term>Thyroid Gland</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Breast Neoplasms</term><term>Carcinoma</term><term>Nasopharyngeal Neoplasms</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Adult</term><term>Female</term><term>Humans</term><term>Male</term><term>Radiation Injuries</term><term>Radiometry</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">The thyroid dysfunction after radiotherapy has led to evaluate the dose received by thyroid during nasopharynx and breast carcinoma irradiation. This evaluation was facilitated by in vivo dosimetry. The aims of this work were to evaluate the thyroid dose and to compare released dose at the reference point in the two localizations.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">14522349</PMID><DateCreated><Year>2003</Year><Month>10</Month><Day>2</Day></DateCreated><DateCompleted><Year>2003</Year><Month>11</Month><Day>12</Day></DateCompleted><DateRevised><Year>2006</Year><Month>11</Month><Day>15</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1278-3218</ISSN><JournalIssue CitedMedium="Print"><Volume>7</Volume><Issue>5</Issue><PubDate><Year>2003</Year><Month>Oct</Month></PubDate></JournalIssue><Title>Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique</Title><ISOAbbreviation>Cancer Radiother</ISOAbbreviation></Journal><ArticleTitle>[Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].</ArticleTitle><Pagination><MedlinePgn>297-301</MedlinePgn></Pagination><Abstract><AbstractText Label="AIMS" NlmCategory="OBJECTIVE">The thyroid dysfunction after radiotherapy has led to evaluate the dose received by thyroid during nasopharynx and breast carcinoma irradiation. This evaluation was facilitated by in vivo dosimetry. The aims of this work were to evaluate the thyroid dose and to compare released dose at the reference point in the two localizations.</AbstractText><AbstractText Label="PATIENTS AND METHODS" NlmCategory="METHODS">A total of 30 patients were evaluated: 18 patients with nasopharynx carcinoma and 12 patients with breast carcinoma were included in the final analysis. In the first group, the total thyroid but the isthmus was irradiated. On the other hand, in the second group, only one thyroid lobe was included into the target volume. All patients have been treated by gamma rays of cobalt 60 and the thyroid absorbed dose was measured by semiconductor dosimeters (Scanditronix DPD6). These dosimeters were calibrated in the same geometric conditions of the irradiation.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">The measured absorbed dose of the thyroid parenchyma was equal to the calculated absorbed dose at the target that has been specified at a depth of -3 cm. Under the block, the isthmus received 5.1 +/- 0.9 Gy (9.9 +/- 1.8%) in nasopharynx carcinoma irradiation. However, in breast carcinoma irradiation, the distal thyroid lobe and the isthmus received 2.9 +/- 0.7 Gy (6.55 +/- 1.56%) and 3.69 +/- 0.77 (8.39 +/- 1.76%), respectively.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study shows that the thyroid received a dose equal to the prescribed dose in both nasopharynx and breast cancer patients. It is recommended to follow the function of the thyroid gland in these patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Besbes</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Service de radiothérapie carcinologique, institut Salah-Azaiz, boulevard du 9-avril-Bab-Saadoun, 1006 Tunis, Tunisie.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Siala</LastName><ForeName>W</ForeName><Initials>W</Initials></Author><Author ValidYN="Y"><LastName>Daoud</LastName><ForeName>J</ForeName><Initials>J</Initials></Author></AuthorList><Language>FRE</Language><PublicationTypeList><PublicationType UI="D016430">Clinical Trial</PublicationType><PublicationType UI="D004740">English Abstract</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><VernacularTitle>Dosimétrie in vivo pour évaluer la dose reçue par la thyroïde en radiothérapie des cancers du cavum et du sein.</VernacularTitle></Article><MedlineJournalInfo><Country>France</Country><MedlineTA>Cancer Radiother</MedlineTA><NlmUniqueID>9711272</NlmUniqueID><ISSNLinking>1278-3218</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001943" MajorTopicYN="N">Breast Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002277" MajorTopicYN="N">Carcinoma</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009303" MajorTopicYN="N">Nasopharyngeal Neoplasms</DescriptorName><QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011832" MajorTopicYN="Y">Radiation Injuries</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011874" MajorTopicYN="N">Radiometry</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013959" MajorTopicYN="N">Thyroid Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D013961" MajorTopicYN="N">Thyroid Gland</DescriptorName><QualifierName UI="Q000528" MajorTopicYN="N">radiation effects</QualifierName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2003</Year><Month>11</Month><Day>13</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2003</Year><Month>10</Month><Day>3</Day><Hour>5</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">14522349</ArticleId><ArticleId IdType="pii">S1278321803000404</ArticleId></ArticleIdList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Terre/explor/CobaltMaghrebV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000073 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 000073 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Terre
|area= CobaltMaghrebV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:14522349
|texte= [Absorbed dose evaluation of thyroid during nasopharynx and breast carcinoma irradiation by in vivo dosimetry].
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:14522349" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a CobaltMaghrebV1
| This area was generated with Dilib version V0.6.32. |  |